STERIS plc (NYSE:STE), a leading provider of infection prevention and procedural products and services with a market capitalization of $21.6 billion, has been navigating a dynamic healthcare landscape ...

DUBLIN, IRELAND, Jan. 28, 2025 (GLOBE NEWSWIRE) -- (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The ...

DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, against Isomedix ...

Pacer Advisors Inc. lessened its holdings in STERIS plc (NYSE:STE – Free Report) by 20.8% during the fourth quarter, ...

KBC Group NV lifted its stake in shares of STERIS plc (NYSE:STE – Free Report) by 14.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange ...

For fiscal 2025, STERIS is expected to deliver an adjusted EPS of $9.10, up nearly 11% from $8.20 in fiscal 2024. While in fiscal 2026, its earnings are expected to surge 10.2% year-over-year to ...

Steris (STE) is expected to deliver a year-over ... insight into the odds of a positive EPS surprise. This medical products maker is expected to post quarterly earnings of $2.32 per share in ...

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by ...